These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Nephropathy in type 1 diabetes. Marre M Semin Vasc Med; 2002 Feb; 2(1):97-107. PubMed ID: 16222600 [TBL] [Abstract][Full Text] [Related]
25. Diabetic woman with massive proteinuria and acute renal failure. Nair R; Said M Am J Kidney Dis; 2005 Aug; 46(2):362-6. PubMed ID: 16112058 [No Abstract] [Full Text] [Related]
26. Allograft diabetic nephropathy may progress to end-stage renal disease. Salifu MO; Nicastri AD; Markell MS; Ghali H; Sommer BG; Friedman EA Pediatr Transplant; 2004 Aug; 8(4):351-6. PubMed ID: 15265161 [TBL] [Abstract][Full Text] [Related]
27. Influence of successful pancreaticorenal transplantation on diabetic retinopathy. Caldara R; Bandello F; ViganĂ² C; Secchi A; Castoldi R; Caldi M; Di Carlo V; Torri G; Pozza G; Brancato R Transplant Proc; 1994 Apr; 26(2):490. PubMed ID: 8171518 [No Abstract] [Full Text] [Related]
28. Promotion, prediction and prevention of progression of nephropathy in type 1 diabetes mellitus. Rossing P Diabet Med; 1998 Nov; 15(11):900-19. PubMed ID: 9827844 [TBL] [Abstract][Full Text] [Related]
29. [Can diabetic nephropathy be prevented?]. Viberti GC; Wiseman M; Mackintosch D; Keen H Journ Annu Diabetol Hotel Dieu; 1983; ():79-88. PubMed ID: 6358621 [No Abstract] [Full Text] [Related]
31. Heparan sulphate in the pathogenesis of diabetic nephropathy. Kofoed-Enevoldsen A Diabetes Metab Rev; 1995 Jul; 11(2):137-60. PubMed ID: 7555565 [No Abstract] [Full Text] [Related]
32. Role of mesangial expansion in the pathogenesis of diabetic nephropathy. Dalla Vestra M; Saller A; Mauer M; Fioretto P J Nephrol; 2001; 14 Suppl 4():S51-7. PubMed ID: 11798146 [TBL] [Abstract][Full Text] [Related]
33. Biochemistry of the basement membrane in diabetes mellitus. Brownlee M; Spiro RG Adv Exp Med Biol; 1979; 124():141-56. PubMed ID: 388998 [No Abstract] [Full Text] [Related]
34. [Glycosaminoglycans in diabetic nephropathy]. Olszowska A Pol Merkur Lekarski; 2000 Dec; 9(54):873-5. PubMed ID: 11255659 [TBL] [Abstract][Full Text] [Related]
35. [Physiopathology of diabetic nephropathy: what we learn from transplantation]. Pirson Y Nephrologie; 1998; 19(3):105-9. PubMed ID: 9633051 [TBL] [Abstract][Full Text] [Related]
37. Controversies on the prevention of diabetic nephropathy. Chiarelli F; Verrotti A; Basciani F; di Ricco L; Sabatino G; Morgese G J Pediatr Endocrinol Metab; 1998 Apr; 11 Suppl 2():365-9. PubMed ID: 9642666 [TBL] [Abstract][Full Text] [Related]
38. [Diabetic nephropathy. Review of the current status and practical considerations concerning etiopathogenetic, clinical and therapeutic aspects]. Martini PF; Segoloni GP; Jeantet A; Giachino G; Mangiarotti G; Nebiolo PE; Longo L; Piancino G Minerva Med; 1980 Oct; 71(38):2709-23. PubMed ID: 7001279 [TBL] [Abstract][Full Text] [Related]
39. Therapeutic interventions in nephropathy of IDDM. Mogensen CE Diabetes Care; 1988; 11 Suppl 1():10-5. PubMed ID: 3069386 [TBL] [Abstract][Full Text] [Related]